Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

FliC's Hypervariable D3 Domain Is Required for Robust Anti-Flagellin Primary Antibody Responses.

López-Yglesias AH, Lu CC, Zhao X, Chou T, VandenBos T, Strong RK, Smith KD.

Immunohorizons. 2019 Sep 5;3(9):422-432. doi: 10.4049/immunohorizons.1800061.

PMID:
31488506
2.

Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes.

Bancroft T, DeBuysscher BL, Weidle C, Schwartz A, Wall A, Gray MD, Feng J, Steach HR, Fitzpatrick KS, Gewe MM, Skog PD, Doyle-Cooper C, Ota T, Strong RK, Nemazee D, Pancera M, Stamatatos L, McGuire AT, Taylor JJ.

J Exp Med. 2019 Jul 25. pii: jem.20190164. doi: 10.1084/jem.20190164. [Epub ahead of print]

PMID:
31345930
3.

Patient HLA Germline Variation and Transplant Survivorship.

Petersdorf EW, Stevenson P, Malkki M, Strong RK, Spellman SR, Haagenson MD, Horowitz MM, Gooley T, Wang T.

J Clin Oncol. 2018 Aug 20;36(24):2524-2531. doi: 10.1200/JCO.2017.77.6534. Epub 2018 Jun 14.

4.

Publisher Correction: Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets.

Crook ZR, Sevilla GP, Friend D, Brusniak MY, Bandaranayake AD, Clarke M, Gewe M, Mhyre AJ, Baker D, Strong RK, Bradley P, Olson JM.

Nat Commun. 2018 Mar 9;9(1):1072. doi: 10.1038/s41467-018-03350-5.

5.

Screening, large-scale production and structure-based classification of cystine-dense peptides.

Correnti CE, Gewe MM, Mehlin C, Bandaranayake AD, Johnsen WA, Rupert PB, Brusniak MY, Clarke M, Burke SE, De Van Der Schueren W, Pilat K, Turnbaugh SM, May D, Watson A, Chan MK, Bahl CD, Olson JM, Strong RK.

Nat Struct Mol Biol. 2018 Mar;25(3):270-278. doi: 10.1038/s41594-018-0033-9. Epub 2018 Feb 26.

6.

Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets.

Crook ZR, Sevilla GP, Friend D, Brusniak MY, Bandaranayake AD, Clarke M, Gewe M, Mhyre AJ, Baker D, Strong RK, Bradley P, Olson JM.

Nat Commun. 2017 Dec 21;8(1):2244. doi: 10.1038/s41467-017-02098-8. Erratum in: Nat Commun. 2018 Mar 9;9(1):1072.

7.

Chelation and stabilization of berkelium in oxidation state +IV.

Deblonde GJ, Sturzbecher-Hoehne M, Rupert PB, An DD, Illy MC, Ralston CY, Brabec J, de Jong WA, Strong RK, Abergel RJ.

Nat Chem. 2017 Sep;9(9):843-849. doi: 10.1038/nchem.2759. Epub 2017 Apr 10.

8.

Control of Tumor Initiation by NKG2D Naturally Expressed on Ovarian Cancer Cells.

Cai X, Caballero-Benitez A, Gewe MM, Jenkins IC, Drescher CW, Strong RK, Spies T, Groh V.

Neoplasia. 2017 Jun;19(6):471-482. doi: 10.1016/j.neo.2017.03.005. Epub 2017 May 9.

9.

Engineered Recognition of Tetravalent Zirconium and Thorium by Chelator-Protein Systems: Toward Flexible Radiotherapy and Imaging Platforms.

Captain I, Deblonde GJ, Rupert PB, An DD, Illy MC, Rostan E, Ralston CY, Strong RK, Abergel RJ.

Inorg Chem. 2016 Nov 21;55(22):11930-11936. Epub 2016 Nov 1.

10.

Disposal of iron by a mutant form of lipocalin 2.

Barasch J, Hollmen M, Deng R, Hod EA, Rupert PB, Abergel RJ, Allred BE, Xu K, Darrah SF, Tekabe Y, Perlstein A, Wax R, Bruck E, Stauber J, Corbin KA, Buchen C, Slavkovich V, Graziano J, Spitalnik SL, Bao G, Strong RK, Qiu A.

Nat Commun. 2016 Oct 31;7:12973. doi: 10.1038/ncomms12973.

11.

HLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1.

Burian A, Wang KL, Finton KA, Lee N, Ishitani A, Strong RK, Geraghty DE.

PLoS One. 2016 Sep 20;11(9):e0163297. doi: 10.1371/journal.pone.0163297. eCollection 2016.

12.

The Broadly Neutralizing, Anti-HIV Antibody 4E10: an Open and Shut Case?

Strong RK, Finton KA.

J Virol. 2016 Feb 26;90(6):3274-5. doi: 10.1128/JVI.02935-15. Print 2016 Mar. No abstract available.

13.

Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice.

McGuire AT, Gray MD, Dosenovic P, Gitlin AD, Freund NT, Petersen J, Correnti C, Johnsen W, Kegel R, Stuart AB, Glenn J, Seaman MS, Schief WR, Strong RK, Nussenzweig MC, Stamatatos L.

Nat Commun. 2016 Feb 24;7:10618. doi: 10.1038/ncomms10618.

14.

Correction for Vigdorovich et al., Expression and Characterization of a Soluble, Active Form of the Jaagsiekte Sheep Retrovirus Receptor, Hyal2.

Vigdorovich V, Strong RK, Miller AD.

J Virol. 2016 Jan 28;90(4):2159. doi: 10.1128/JVI.03001-15. Print 2016 Feb 15. No abstract available.

15.

Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides.

Allred BE, Rupert PB, Gauny SS, An DD, Ralston CY, Sturzbecher-Hoehne M, Strong RK, Abergel RJ.

Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10342-7. doi: 10.1073/pnas.1508902112. Epub 2015 Aug 3.

16.

Anti-CD28 Antibody-Initiated Cytokine Storm in Canines.

Rosinski SL, Storb R, Strong RK, Sale GE, Stone DM, Gewe MM, Friend DJ, Abrams VK, Randolph-Habecker J, Graves SS.

Transplant Direct. 2015 Mar;1(2). doi: 10.1097/TXD.0000000000000516.

17.

Inhibition and Reversal of Microbial Attachment by an Antibody with Parasteric Activity against the FimH Adhesin of Uropathogenic E. coli.

Kisiela DI, Avagyan H, Friend D, Jalan A, Gupta S, Interlandi G, Liu Y, Tchesnokova V, Rodriguez VB, Sumida JP, Strong RK, Wu XR, Thomas WE, Sokurenko EV.

PLoS Pathog. 2015 May 14;11(5):e1004857. doi: 10.1371/journal.ppat.1004857. eCollection 2015 May.

18.

Lipocalin 2 imparts selective pressure on bacterial growth in the bladder and is elevated in women with urinary tract infection.

Steigedal M, Marstad A, Haug M, Damås JK, Strong RK, Roberts PL, Himpsl SD, Stapleton A, Hooton TM, Mobley HL, Hawn TR, Flo TH.

J Immunol. 2014 Dec 15;193(12):6081-9. doi: 10.4049/jimmunol.1401528. Epub 2014 Nov 14.

19.

Ontogeny of recognition specificity and functionality for the broadly neutralizing anti-HIV antibody 4E10.

Finton KA, Friend D, Jaffe J, Gewe M, Holmes MA, Larman HB, Stuart A, Larimore K, Greenberg PD, Elledge SJ, Stamatatos L, Strong RK.

PLoS Pathog. 2014 Sep 25;10(9):e1004403. doi: 10.1371/journal.ppat.1004403. eCollection 2014 Sep.

20.

Proof of principle for epitope-focused vaccine design.

Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, Serra AM, Adachi Y, Holmes MA, Li Y, Klevit RE, Graham BS, Wyatt RT, Baker D, Strong RK, Crowe JE Jr, Johnson PR, Schief WR.

Nature. 2014 Mar 13;507(7491):201-6. doi: 10.1038/nature12966. Epub 2014 Feb 5.

21.

Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway.

López-Yglesias AH, Zhao X, Quarles EK, Lai MA, VandenBos T, Strong RK, Smith KD.

J Immunol. 2014 Feb 15;192(4):1587-96. doi: 10.4049/jimmunol.1301893. Epub 2014 Jan 17.

22.

Ligand binding-dependent functions of the lipocalin NLaz: an in vivo study in Drosophila.

Ruiz M, Ganfornina MD, Correnti C, Strong RK, Sanchez D.

FASEB J. 2014 Apr;28(4):1555-67. doi: 10.1096/fj.13-240556. Epub 2013 Dec 20.

23.

Autoreactivity and exceptional CDR plasticity (but not unusual polyspecificity) hinder elicitation of the anti-HIV antibody 4E10.

Finton KA, Larimore K, Larman HB, Friend D, Correnti C, Rupert PB, Elledge SJ, Greenberg PD, Strong RK.

PLoS Pathog. 2013;9(9):e1003639. doi: 10.1371/journal.ppat.1003639. Epub 2013 Sep 26.

24.

Lipid-binding properties of human ApoD and Lazarillo-related lipocalins: functional implications for cell differentiation.

Ruiz M, Sanchez D, Correnti C, Strong RK, Ganfornina MD.

FEBS J. 2013 Aug;280(16):3928-43. doi: 10.1111/febs.12394. Epub 2013 Jul 10.

25.

Siderocalin outwits the coordination chemistry of vibriobactin, a siderophore of Vibrio cholerae.

Allred BE, Correnti C, Clifton MC, Strong RK, Raymond KN.

ACS Chem Biol. 2013 Sep 20;8(9):1882-7. doi: 10.1021/cb4002552. Epub 2013 Jun 18.

26.

Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.

Hoot S, McGuire AT, Cohen KW, Strong RK, Hangartner L, Klein F, Diskin R, Scheid JF, Sather DN, Burton DR, Stamatatos L.

PLoS Pathog. 2013 Jan;9(1):e1003106. doi: 10.1371/journal.ppat.1003106. Epub 2013 Jan 3. Erratum in: PLoS Pathog. 2013 Jul;9(9). doi:10.1371/annotation/ed7c0148-97eb-4416-824d-6e6d1aaeceef.

27.

Structural insights into activation of antiviral NK cell responses.

Finton KA, Strong RK.

Immunol Rev. 2012 Nov;250(1):239-57. doi: 10.1111/j.1600-065X.2012.01168.x. Review.

28.

Siderocalin/Lcn2/NGAL/24p3 does not drive apoptosis through gentisic acid mediated iron withdrawal in hematopoietic cell lines.

Correnti C, Richardson V, Sia AK, Bandaranayake AD, Ruiz M, Suryo Rahmanto Y, Kovačević Ž, Clifton MC, Holmes MA, Kaiser BK, Barasch J, Raymond KN, Richardson DR, Strong RK.

PLoS One. 2012;7(8):e43696. doi: 10.1371/journal.pone.0043696. Epub 2012 Aug 21.

29.

Mammalian siderophores, siderophore-binding lipocalins, and the labile iron pool.

Correnti C, Strong RK.

J Biol Chem. 2012 Apr 20;287(17):13524-31. doi: 10.1074/jbc.R111.311829. Epub 2012 Mar 2. Review.

30.

Galline Ex-FABP is an antibacterial siderocalin and a lysophosphatidic acid sensor functioning through dual ligand specificities.

Correnti C, Clifton MC, Abergel RJ, Allred B, Hoette TM, Ruiz M, Cancedda R, Raymond KN, Descalzi F, Strong RK.

Structure. 2011 Dec 7;19(12):1796-806. doi: 10.1016/j.str.2011.09.019.

31.

Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold.

Azoitei ML, Correia BE, Ban YE, Carrico C, Kalyuzhniy O, Chen L, Schroeter A, Huang PS, McLellan JS, Kwong PD, Baker D, Strong RK, Schief WR.

Science. 2011 Oct 21;334(6054):373-6. doi: 10.1126/science.1209368.

32.

Immune interference in Mycobacterium tuberculosis intracellular iron acquisition through siderocalin recognition of carboxymycobactins.

Hoette TM, Clifton MC, Zawadzka AM, Holmes MA, Strong RK, Raymond KN.

ACS Chem Biol. 2011 Dec 16;6(12):1327-31. doi: 10.1021/cb200331g. Epub 2011 Oct 21.

33.

Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors.

Bandaranayake AD, Correnti C, Ryu BY, Brault M, Strong RK, Rawlings DJ.

Nucleic Acids Res. 2011 Nov;39(21):e143. doi: 10.1093/nar/gkr706. Epub 2011 Sep 12.

34.

High-resolution structure prediction of a circular permutation loop.

Correia BE, Holmes MA, Huang PS, Strong RK, Schief WR.

Protein Sci. 2011 Nov;20(11):1929-34. doi: 10.1002/pro.725. Epub 2011 Sep 30.

35.

Binding interactions between soluble HIV envelope glycoproteins and quaternary-structure-specific monoclonal antibodies PG9 and PG16.

Davenport TM, Friend D, Ellingson K, Xu H, Caldwell Z, Sellhorn G, Kraft Z, Strong RK, Stamatatos L.

J Virol. 2011 Jul;85(14):7095-107. doi: 10.1128/JVI.00411-11. Epub 2011 May 4.

36.

Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA.

Xu B, Pizarro JC, Holmes MA, McBeth C, Groh V, Spies T, Strong RK.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2414-9. doi: 10.1073/pnas.1015433108. Epub 2011 Jan 24.

37.

Computational protein design using flexible backbone remodeling and resurfacing: case studies in structure-based antigen design.

Correia BE, Ban YE, Friend DJ, Ellingson K, Xu H, Boni E, Bradley-Hewitt T, Bruhn-Johannsen JF, Stamatatos L, Strong RK, Schief WR.

J Mol Biol. 2011 Jan 7;405(1):284-97. doi: 10.1016/j.jmb.2010.09.061. Epub 2010 Oct 20.

PMID:
20969873
38.

Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope.

Correia BE, Ban YE, Holmes MA, Xu H, Ellingson K, Kraft Z, Carrico C, Boni E, Sather DN, Zenobia C, Burke KY, Bradley-Hewitt T, Bruhn-Johannsen JF, Kalyuzhniy O, Baker D, Strong RK, Stamatatos L, Schief WR.

Structure. 2010 Sep 8;18(9):1116-26. doi: 10.1016/j.str.2010.06.010.

39.

The structural basis of 5' triphosphate double-stranded RNA recognition by RIG-I C-terminal domain.

Lu C, Xu H, Ranjith-Kumar CT, Brooks MT, Hou TY, Hu F, Herr AB, Strong RK, Kao CC, Li P.

Structure. 2010 Aug 11;18(8):1032-43. doi: 10.1016/j.str.2010.05.007. Epub 2010 Jul 15.

40.

Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex.

Bao G, Clifton M, Hoette TM, Mori K, Deng SX, Qiu A, Viltard M, Williams D, Paragas N, Leete T, Kulkarni R, Li X, Lee B, Kalandadze A, Ratner AJ, Pizarro JC, Schmidt-Ott KM, Landry DW, Raymond KN, Strong RK, Barasch J.

Nat Chem Biol. 2010 Aug;6(8):602-9. doi: 10.1038/nchembio.402. Epub 2010 Jun 27.

41.

Intracellular Mycobacterium avium intersect transferrin in the Rab11(+) recycling endocytic pathway and avoid lipocalin 2 trafficking to the lysosomal pathway.

Halaas O, Steigedal M, Haug M, Awuh JA, Ryan L, Brech A, Sato S, Husebye H, Cangelosi GA, Akira S, Strong RK, Espevik T, Flo TH.

J Infect Dis. 2010 Mar;201(5):783-92. doi: 10.1086/650493.

42.

Interactions between lipids and human anti-HIV antibody 4E10 can be reduced without ablating neutralizing activity.

Xu H, Song L, Kim M, Holmes MA, Kraft Z, Sellhorn G, Reinherz EL, Stamatatos L, Strong RK.

J Virol. 2010 Jan;84(2):1076-88. doi: 10.1128/JVI.02113-09. Epub 2009 Nov 11.

43.

Structural basis of double-stranded RNA recognition by the RIG-I like receptor MDA5.

Li X, Lu C, Stewart M, Xu H, Strong RK, Igumenova T, Li P.

Arch Biochem Biophys. 2009 Aug 1;488(1):23-33. doi: 10.1016/j.abb.2009.06.008. Epub 2009 Jun 14.

PMID:
19531363
44.

Lipocalin 2 is required for pulmonary host defense against Klebsiella infection.

Chan YR, Liu JS, Pociask DA, Zheng M, Mietzner TA, Berger T, Mak TW, Clifton MC, Strong RK, Ray P, Kolls JK.

J Immunol. 2009 Apr 15;182(8):4947-56. doi: 10.4049/jimmunol.0803282.

45.

Lipocalin 2 promotes breast cancer progression.

Yang J, Bielenberg DR, Rodig SJ, Doiron R, Clifton MC, Kung AL, Strong RK, Zurakowski D, Moses MA.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3913-8. doi: 10.1073/pnas.0810617106. Epub 2009 Feb 23.

46.

Siderocalins: siderophore-binding proteins of the innate immune system.

Clifton MC, Corrent C, Strong RK.

Biometals. 2009 Aug;22(4):557-64. doi: 10.1007/s10534-009-9207-6. Epub 2009 Jan 30. Review.

PMID:
19184458
47.

The role of electrostatics in siderophore recognition by the immunoprotein Siderocalin.

Hoette TM, Abergel RJ, Xu J, Strong RK, Raymond KN.

J Am Chem Soc. 2008 Dec 24;130(51):17584-92. doi: 10.1021/ja8074665.

48.

Synthesis of carbapyochelins via diastereoselective azidation of 5-(ethoxycarbonyl)methylproline derivatives.

Liyanage W, Weerasinghe L, Strong RK, Del Valle JR.

J Org Chem. 2008 Sep 19;73(18):7420-3. doi: 10.1021/jo801294p. Epub 2008 Aug 13.

49.

The siderocalin/enterobactin interaction: a link between mammalian immunity and bacterial iron transport.

Abergel RJ, Clifton MC, Pizarro JC, Warner JA, Shuh DK, Strong RK, Raymond KN.

J Am Chem Soc. 2008 Aug 27;130(34):11524-34. doi: 10.1021/ja803524w. Epub 2008 Aug 5.

50.

Structural basis for NKG2A/CD94 recognition of HLA-E.

Kaiser BK, Pizarro JC, Kerns J, Strong RK.

Proc Natl Acad Sci U S A. 2008 May 6;105(18):6696-701. doi: 10.1073/pnas.0802736105. Epub 2008 Apr 30.

Supplemental Content

Loading ...
Support Center